TORLEY HELEN (PRESIDENT AND CEO) sold 6.1% of their position (50K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.48M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$12.07
Trade value
$241.40K
% of position
Common Stock
Shares
−4.10K
Price / share
$69.20
Trade value
$283.71K
% of position
Common Stock
Shares
−15.32K
Price / share
$69.80
Trade value
$1.07M
% of position
Common Stock
Shares
−578.00
Price / share
$70.46
Trade value
$40.73K
% of position
Common Stock
Shares
+20K
Price / share
$12.07
Trade value
$241.40K
% of position
Common Stock
Shares
−13.48K
Price / share
$68.85
Trade value
$928.17K
% of position
Common Stock
Shares
−6.52K
Price / share
$69.33
Trade value
$451.98K
% of position
Common Stock
Shares
+10K
Price / share
$12.07
Trade value
$120.70K
% of position
Common Stock
Shares
−7.33K
Price / share
$69.94
Trade value
$512.62K
% of position
Common Stock
Shares
−2.67K
Price / share
$70.94
Trade value
$189.49K
% of position
Net shares
+0.00
Net value
-$2.87M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | M · Option Exercise | +20K | $12.07 | $241.40K | 2.6% | 767.78K | 787.78K |
| Common Stock Direct | 3/2/2026 | S · Sale | −4.10K | $69.20 | $283.71K | 0.5% | 787.78K | 783.68K |
| Common Stock Direct | 3/2/2026 | S · Sale | −15.32K | $69.80 | $1.07M | 2.0% | 783.68K | 768.36K |
| Common Stock Direct | 3/2/2026 | S · Sale | −578.00 | $70.46 | $40.73K | 0.1% | 768.36K | 767.78K |
| Common Stock Direct | 3/3/2026 | M · Option Exercise | +20K | $12.07 | $241.40K | 2.6% | 767.78K | 787.78K |
| Common Stock Direct | 3/3/2026 | S · Sale | −13.48K | $68.85 | $928.17K | 1.7% | 787.78K | 774.30K |
| Common Stock Direct | 3/3/2026 | S · Sale | −6.52K | $69.33 | $451.98K | 0.8% | 774.30K | 767.78K |
| Common Stock Direct | 3/4/2026 | M · Option Exercise | +10K | $12.07 | $120.70K | 1.3% | 767.78K | 777.78K |
| Common Stock Direct | 3/4/2026 | S · Sale | −7.33K | $69.94 | $512.62K | 0.9% | 777.78K | 770.45K |
| Common Stock Direct | 3/4/2026 | S · Sale | −2.67K | $70.94 | $189.49K | 0.3% | 770.45K | 767.78K |
| Total | +0.00 | -$2.87M | ||||||
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
12.07
Held after
181.92K
Exercisable
—
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
12.07
Held after
161.92K
Exercisable
—
Option to Purchase Common Stock
Common Stock
10K shares
Shares
−10K
Strike price
12.07
Held after
151.92K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock20K shares | 3/2/2026 | M · Option Exercise | −20K | 12.07 | — | 181.92K |
| Option to Purchase Common Stock Direct | Common Stock20K shares | 3/3/2026 | M · Option Exercise | −20K | 12.07 | — | 161.92K |
| Option to Purchase Common Stock Direct | Common Stock10K shares | 3/4/2026 | M · Option Exercise | −10K | 12.07 | — | 151.92K |